A new study published in JAMA Network Open by Hanna Heyman and colleagues provides important insights into how colorectal ...

FOBT-positive patients who skipped colonoscopy had fourfold higher cancer incidence ...

Higher endoscopist polyp detection rates are significantly associated with fewer negative colonoscopies after positive stool tests, suggesting the need for new detection benchmarks, researchers say.

Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted ...

INDIANAPOLIS – Screening for colorectal cancer presents a unique opportunity unavailable for most other types of cancers. Screening allows for the detection of both precancerous polyps and cancer, ...

March is colorectal cancer awareness month. A doctor with Anthem Blue Cross and Blue Shield spoke with WYSO about Ohio cancer ...

SAN DIEGO — For patients with a positive fecal immunochemical test, the risk for colorectal cancer increases if diagnostic colonoscopy is delayed beyond 6 months, according to new research. "In breast ...

A study of 316,443 patients shows that 7.4% of patients repeated fecal testing rather than proceeding directly to colonoscopy as guidelines recommend, and of those who repeated home tests, over half ...

Stool-based DNA testing can help bridge CRC screening gaps between rural and urban populations by providing timely follow-up. The study found no significant difference in follow-up times for ...

Doctors say there are less invasive screening options for colon cancer, but each comes with tradeoffs.

Data presentations include positive impact of eliminating patient cost for follow-up colonoscopies, shifting to non-invasive colorectal cancer testing, and increasing overall screening as 900 deaths ...

Phase II study of NALIRIFOX (nanoliposomal irinotecan + oxaliplatin with fluorouracil and folinic acid) in advanced unresectable small bowel tumors. Inappropriate use of tumor markers for GI cancer ...